← Back to Search

Procedure

1 for Colorectal Cancer (COLORII Trial)

Phase 3
Waitlist Available
Led By Jaap Bonjer, MD, PhD
Research Sponsored by Jaap Bonjer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up seven years
Awards & highlights

COLORII Trial Summary

COLOR II is a randomized, international, multi center study comparing the outcomes of laparoscopic and conventional resection of rectal carcinoma below 15 cm with curative intent. Clinical and operative data will be collected centrally in the coordinating centre in Halifax, Canada. Quality of life and costs will be assessed on a national basis.

Eligible Conditions
  • Colorectal Cancer

COLORII Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~seven years
This trial's timeline: 3 weeks for screening, Varies for treatment, and seven years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
locoregional recurrence rate
Secondary outcome measures
distant metastases rate
duration of absence of work
duration of in-hospital stay
+8 more

COLORII Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
surgery (open or laparoscopic) and observation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
surgery
2005
Completed Phase 4
~6010

Find a Location

Who is running the clinical trial?

Jaap BonjerLead Sponsor
Jaap Bonjer, MD, PhDPrincipal InvestigatorDalhousie University, and VUMC, the Netherlands
1 Previous Clinical Trials
1,200 Total Patients Enrolled
Marius HoogerboordPrincipal InvestigatorNova Scotia Health Authority

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~53 spots leftby Apr 2025